EastPharma has two main operating companies in its portfolio: Deva Holding, the main asset, and specialty pharma company, Saba Pharmaceuticals, which was acquired in 2007.

Deva Holding, in which EastPharma holds a 93.54% total stake of C shares, is one of Turkey's largest pharmaceutical groups. The company is predominantly active in human pharmaceutical products; API (active pharmaceutical ingredient) manufacturing; and veterinary products. Apart from its core pharma business, Deva is also involved in the production and sale of consumer goods. Deva's subsidiaries are:

• Carlo Erba - Human pharmaceuticals
• Depa - APIs
• Vetaş - Veterinary products, insurance brokerage and catering
• Detaş - Consumer goods and ampoules
• Deva Health Care - Hygienic products

SABA Pharmaceuticals, in which EastPharma owns the entire A, B, C and D shares. A total of 4.5% of the founder shares are still owned by the founders. Saba, which has been in operation for 20 years, has an established presence and distribution activities in over 18 countries including the Middle East and the US. Saba's product portfolio includes higher-end products, especially in the cardiovascular and painkiller fields.


Deva Holding A.Ş.
http://www.deva.com.tr/